Is There a Correlation Between Serum SFRP5 and Wnt5a Proteins and Insulin Resistance in Iraqi Infertile Females Undergoing ICSI? | ||
| Al- Anbar Medical Journal | ||
| Article 13, Volume 19, Issue 2, December 2023, Pages 155-161 PDF (342.15 K) | ||
| Document Type: Original articles | ||
| DOI: 10.33091/amj.2023.141909.1273 | ||
| Authors | ||
| Hameedah Abdull hussen Mohsin* 1; Mufeeda Ali Jwad2; Hayder Ali Lafta2 | ||
| 1High Institute for Infertility Diagnosis and Assisted Reproductive Technologies, Al- Nahrain University, Bagdad, Iraq | ||
| 2Assist. Prof. at the High Institute of Infertility Diagnosis and Assisted Reproductive Technologies, Al-Nahrain University, Baghdad, Iraq | ||
| Abstract | ||
| Background: Secreted frizzled-related protein 5 (SFRP5) is an adipokine that inhibits the noncanonical Wingless Type (Wnt) signalling pathway. It may have anti-inflammatory and insulin-sensitizing effects, but the evidence is conflicting. Objectives: This study examined the influence of serum and follicular fluid levels of SFRP5 and Wnt5a on intracytoplasmic sperm injection (ICSI) outcomes in infertile women, considering their relationship to insulin sensitivity. Materials and Methods: Ninety infertile women aged 18 to 45 years undergoing ICSI for various reasons were enrolled in this prospective cross-sectional study at the infertility centre of the High Institute for Infertility Diagnosis and Assisted Reproductive Technologies, Al-Nahrain University, Baghdad, Iraq, from September 2021 to July 2023. They received antagonist ovarian hyperstimulation treatment and had their blood fasting sugar, serum fasting insulin, serum and follicular fluid SFRP5, and serum and follicular fluid Wnt5a measured on ovum pickup. The Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) was calculated. Results: Serum and follicular fluid SFRP5 levels were higher in normal-weight women (P-value < 0.001), while serum and follicular fluid Wnt5a levels were insignificantly higher in obese women (P-value > 0.05). HOMA-IR was higher in the obese group (P-value < 0.001). Insulin resistance markers were lower in pregnant women (P-value < 0.05), while serum and follicular fluid SFRP5 levels were higher in pregnant women (P-value < 0.01). Serum and follicular fluid SFRP5 levels were negatively correlated with insulin resistance markers and positively correlated with oocyte quality, quantity, fertilization rate, and embryo grade (P-value < 0.05). Conclusion: SFRP5 and Wnt5a were detected in infertile women's serum and follicular fluid. Serum and follicular fluid SFRP5 levels were associated with lower insulin resistance, a lower body mass index, and better ICSI outcomes. | ||
| Keywords | ||
| Obesity; Secreted frizzled-related protein 5; Wingless Type Mouse Mammary tumor virus integration site; Homeostatic Model Assessment; Insulin Resistance | ||
| References | ||
|
[1] R. Z. Al-yasiry, M. A. Jwad, M. F. Hasan, and H. A. Alsayigh, "How obesity affects female fertility," Med j Babylon, vol. 19, pp. 111-4, 2022.
[2] M. Rydzewska, A. Nikołajuk, N. Matulewicz, M. Stefanowicz, and M. Karczewska-Kupczewska, "Serum secreted frizzled-related protein 5 in relation to insulin sensitivity and its regulation by insulin and free fatty acids," Endocrine, vol. 74, pp. 300-307, 2021.
[3] Z. O. Inal, H. A. Inal, and S. Erdem, "The effect of serum and follicular fluid secreted frizzle-related protein-5 on in vitro fertilization outcomes in patients with polycystic ovary syndrome," Molecular biology reports, vol. 45, pp. 2037-2044, 2018.
[4] J. J. Fuster et al., "Noncanonical Wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion," Diabetes, vol. 64, no. 4, pp. 1235-1248, 2015.
[5] D. Koutaki, A. Michos, F. Bacopoulou, and E. Charmandari, "The emerging role of Sfrp5 and Wnt5a in the pathogenesis of obesity: implications for a healthy diet and lifestyle," Nutrients, vol. 13, no. 7, p. 2459, 2021.
[6] I. Relling et al., "Role of wnt5a in metabolic inflammation in humans," The Journal of Clinical Endocrinology & Metabolism, vol. 103, no. 11, pp. 4253-4264, 2018.
[7] F. Hussam et al., "A Cross-Sectional Study Regarding Infertility Among Women in Iraq," Journal of Obstetrics, Gynecology and Cancer Research, vol. 8, no. 1, pp. 47-52, 2023.
[8] NICE. "Fertility problems: assessment and treatment." National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/cg156 (accessed September 1, 2023).
[9] I. M. Magaton, A. Helmer, M. Eisenhut, M. Roumet, P. Stute, and M. von Wolff, "Oocyte maturity, oocyte fertilization and cleavage-stage embryo morphology are better in natural compared with high-dose gonadotrophin stimulated IVF cycles," Reproductive biomedicine online, vol. 46, no. 4, pp. 705-712, 2023.
[10] B. Balaban and A. Thornhill, "Alpha–Scientists in Reproductive Medicine," Reproductive BioMedicine Online, no. 23, p. 68, 2011.
[11] Y. Zhang et al., "Diagnostic value of a single β-hCG test in predicting reproductive outcomes in women undergoing cleavage embryo transfer: a retrospective analysis from a single center," Reproductive Health, vol. 19, no. 1, pp. 1-9, 2022.
[12] Ş. Demir and B. A. Çelik, "Ability of Metabolic Score for Insulin Resistance to Detect Insulin Resistance: Metabolic Score for Insulin Resistance," Chronicles of Precision Medical Researchers, vol. 3, no. 3, pp. 187-192, 2022.
[13] S. Pengpid and K. Peltzer, "Overweight and obesity among adults in Iraq: prevalence and correlates from a National Survey in 2015," International journal of environmental research and public health, vol. 18, no. 8, p. 4198, 2021.
[14] D. Gautam et al., "The challenges of obesity for fertility: A FIGO literature review," International Journal of Gynecology & Obstetrics, vol. 160, pp. 50-55, 2023.
[15] Q. Tang et al., "Wnt5a regulates the cell proliferation and adipogenesis via MAPK‐independent pathway in early stage of obesity," Cell biology international, vol. 42, no. 1, pp. 63-74, 2018.
[16] T. Motawi, O. Shaker, M. Ismail, and N. Sayed, "Peroxisome proliferator-activated receptor gamma in obesity and colorectal cancer: the role of epigenetics," Scientific reports, vol. 7, no. 1, pp. 1-8, 2017.
[17] R. Wang et al., "SFRP5 acts as a mature adipocyte marker but not as a regulator in adipogenesis," Journal of molecular endocrinology, vol. 53, no. 3, pp. 405-415, 2014.
[18] X. He and H. Ma, "Correlation between circulating levels of secreted frizzled-related protein 5 and type 2 diabetic patients and subjects with impaired-glucose regulation," Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, vol. 13, p. 1243, 2020.
[19] I. Akoumianakis et al., "Adipose tissue–derived WNT5A regulates vascular redox signaling in obesity via USP17/RAC1-mediated activation of NADPH oxidases," Science translational medicine, vol. 11, no. 510, p. eaav5055, 2019.
[20] C. Koebnick et al., "A diet high in sugar-sweetened beverage and low in fruits and vegetables is associated with adiposity and a pro-inflammatory adipokine profile," British Journal of Nutrition, vol. 120, no. 11, pp. 1230-1239, 2018.
[21] M. Carstensen-Kirberg et al., "Inverse associations between serum levels of secreted frizzled-related protein-5 (SFRP5) and multiple cardiometabolic risk factors: KORA F4 study," Cardiovascular Diabetology, vol. 16, no. 1, pp. 1-10, 2017.
[22] S. Canivell et al., "Circulating SFRP5 levels are elevated in drug‐naive recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls," Diabetes/Metabolism Research and Reviews, vol. 31, no. 2, pp. 212-219, 2015.
[23] M. Carstensen et al., "Effect of Sfrp5 on cytokine release and insulin action in primary human adipocytes and skeletal muscle cells," PLoS One, vol. 9, no. 1, p. e85906, 2014.
[24] A. E. Khalaf Allah, S. F. Elmekkawi, A. MEGAHED, and A. H. Megahed, "Obesity Index That Better Predict Ovarian Response: Body Mass Index, Waist Circumference, Waist Hip Ratio, or Waist Height Ratio in Women Undergoing ICSI: A Pilot Study," Evidence Based Women's Health Journal, vol. 10, no. 1, pp. 54-64, 2020.
[25] M.-C. Li et al., "Waist circumference in relation to outcomes of infertility treatment with assisted reproductive technologies," American journal of obstetrics and gynecology, vol. 220, no. 6, pp. 578. e1-578. e13, 2019.
[26] H. Song, Z. Yu, P. Li, Y. Wang, and Y. Shi, "HOMA-IR for predicting clinical pregnancy rate during IVF," Gynecological Endocrinology, vol. 38, no. 1, pp. 33-38, 2022.
[27] M. G. Farb et al., "WNT5A-JNK regulation of vascular insulin resistance in human obesity," Vascular Medicine, vol. 21, no. 6, pp. 489-496, 2016.
[28] M. F. Hassan, M. A. Jawad, and R. Z. Al-yasiry, "Does Insulin Resistance (IR) Have an Impact on The Reproductive and Fertility Potential in Polycystic Ovary Syndrome (PCOS) Women?," Maaen Journal for Medical Sciences, vol. 2, no. 1, p. 3, 2023. | ||
|
Statistics Article View: 238 PDF Download: 173 |
||